Abstract:Abstract Background DNA microarrays are rapidly becoming a fundamental tool in discovery-based genomic and biomedical research. However, the reliability of the microarray results is being challenged due to the existence of different technologies and non-standard methods of data analysis and interpretation. In the absence of a "gold standard"/"reference method" for the gene expression measurements, studies evaluating and comparing the performance of various microarray platforms have often yielded subjective and conflicting conclusions. To address this issue we have conducted a large scale TaqMan ® Gene Expression Assay based real-time PCR experiment and used this data set as the reference to evaluate the performance of two representative commercial microarray platforms. Results In this study, we analyzed the gene expression profiles of three human tissues: brain, lung, liver and one universal human reference sample (UHR) using two representative commercial long-oligonucleotide microarray platforms: (1) Applied Biosystems Human Genome Survey Microarrays (based on single-color detection); (2) Agilent Whole Human Genome Oligo Microarrays (based on two-color detection). 1,375 genes represented by both microarray platforms and spanning a wide dynamic range in gene expression levels, were selected for TaqMan ® Gene Expression Assay based real-time PCR validation. For each platform, four technical replicates were performed on the same total RNA samples according to each manufacturer's standard protocols. For Agilent arrays, comparative hybridization was performed using incorporation of Cy5 for brain/lung/liver RNA and Cy3 for UHR RNA (common reference). Using the TaqMan ® Gene Expression Assay based real-time PCR data set as the reference set, the performance of the two microarray platforms was evaluated focusing on the following criteria: (1) Sensitivity and accuracy in detection of expression; (2) Fold change correlation with real-time PCR data in pair-wise tissues as well as in gene expression profiles determined across all tissues; (3) Sensitivity and accuracy in detection of differential expression. Conclusion Our study provides one of the largest "reference" data set of gene expression measurements using TaqMan ® Gene Expression Assay based real-time PCR technology. This data set allowed us to use an alternative gene expression technology to evaluate the performance of different microarray platforms. We conclude that microarrays are indeed invaluable discovery tools with acceptable reliability for genome-wide gene expression screening, though validation of putative changes in gene expression remains advisable. Our study also characterizes the limitations of microarrays; understanding these limitations will enable researchers to more effectively evaluate microarray results in a more cautious and appropriate manner.

Quality assurance of RNA expression profiling in clinical laboratories

Clinical Implementation of RNA Signatures for Pharmacogenomic Decision-Making.

Quality assessment and data handling methods for Affymetrix Gene 1.0 ST arrays with variable RNA integrity

Selecting Reliable Mrna Expression Measurements Across Platforms Improves Downstream Analysis

Reproducible and Reliable Microarray Results Through Quality Control: Good Laboratory Proficiency and Appropriate Data Analysis Practices Are Essential

A Real-World Multi-Center RNA-seq Benchmarking Study Using the Quartet and MAQC Reference Materials

Toward Best Practice in Identifying Subtle Differential Expression with RNA-seq: A Real-World Multi-Center Benchmarking Study Using Quartet and MAQC Reference Materials

Critical assay parameters facilitating confident detection of expression changes, fusions and short variants in RNA isolated from tissue

Improper preanalytical processes on peripheral blood compromise RNA quality and skew the transcriptional readouts of mRNA and LncRNA

Comprehensive Assessments of RNA-seq by the SEQC Consortium: FDA-Led Efforts Advance Precision Medicine

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies.

QA/QC Issues to Aid Regulatory Acceptance of Microarray Gene Expression Data

Translating RNA sequencing into clinical diagnostics: opportunities and challenges

Tissue Handling and Specimen Preparation in Surgical Pathology: Issues Concerning the Recovery of Nucleic Acids From Formalin-Fixed, Paraffin-Embedded Tissue

Developing an effective quality evaluation strategy of next-generation sequencing for accurate detecting non-small cell lung cancer samples with variable characteristics: a real-world clinical practice

Clinical validation of RNA sequencing for Mendelian disorder diagnostics

Systematic evaluation of medium-throughput mRNA abundance platforms

Quality Assessment for Short Oligonucleotide Microarray Data

Impact of RNA-seq data analysis algorithms on gene expression estimation and downstream prediction

Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays